Search

Displaying results 1221 - 1230 of 10000 in total
  1. Drug

    N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine

    go.drugbank.com/drugs/DB08056
    Experimental

    Synonyms: N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine
  2. Drug

    6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE

    go.drugbank.com/drugs/DB07206
    Experimental

    Synonyms: 6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE
  3. Drug

    6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE

    go.drugbank.com/drugs/DB07245
    Experimental

    Synonyms: 6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE
  4. Drug

    Racecadotril

    go.drugbank.com/drugs/DB11696
    Investigational

    Racecadotril has been investigated for the basic science and treatment of Diarrhea, Acute Diarrhea, and Acute Gastroenteritis.

    Products: HIDRASEC GRANULOS 10 MG, RESORCAL 10 MG GRANULADO
  5. Drug

    Dapsone

    go.drugbank.com/drugs/DB00250
    ApprovedInvestigational

    A sulfone active against a wide range of bacteria but mainly employed for its actions against mycobacterium leprae.

    Products: Dapsone 100 mg, DAPSULON® 100 MG
  6. Pathway

    Cardiolipin Biosynthesis CL(10:0/10:0/10:0/18:2(9Z,11Z))

    smpdb.ca/view/SMP0175283
    Metabolic

    Cardiolipin biosynthesis occurs mainly in the mitochondria, but there also exists an alternative synthesis route for CDP-diacylglycerol that takes place in the endoplasmic reticulum.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  7. Drug

    Beractant

    go.drugbank.com/drugs/DB06761
    Approved

    The final composition provides 25 mg/mL phospholipids (including 11.0-15.5 mg/mL disaturated phosphatidylcholine), 0.5-1.75 mg/mL triglycerides, 1.4-3.5 mg/mL free fatty acids, and less than 1.0 mg/mL

    Products: Alveofact 45 mg/ml Pulver und Lösungsmittel zur Herstellung einer Suspension zur endotracheopulmonalen Instillation, SURVANTA INTRATRAKEAL SUSPANSIYON, 1 ADET
  8. Drug

    Prucalopride

    go.drugbank.com/drugs/DB06480
    ApprovedInvestigational

    [A40254] Prucalopride was developed by Shire Development LLC and approved for use in Europe in 2009,[A40250] in Canada on December 7, 2011 and by the FDA on December 17, 2018.[L4880]

    Products: Resolor Film-coated Tablet 1 mg, RESOLOR ® TABLETAS RECUBIERTAS DE 1 MG
  9. Drug

    Thallous chloride

    go.drugbank.com/drugs/DB09316
    ApprovedWithdrawn

    Thallous chloride (also known as Thallium(I) chloride) is a colourless solid intermediate in the isolation of thallium from its ores. It is created from the treatment of thallium(I) sulfate with hydrochloric acid. This solid crystallizes...

    Products: TAEK-PHT 201-TlCl (TALYUM KLORÜR) 37 MBQ/ML IV ENJEKSİYONLUK ÇÖZELTİ, 1 ADET, THALLOUS CHLORIDE (Tl201) INJECTION 37 MBq/ml
  10. Drug

    Enzalutamide

    go.drugbank.com/drugs/DB08899
    ApprovedInvestigational

    Compared to the average time of 10 to 15 years for a drug to go from pre-clinical to clinical studies, enzalutamide was developed relatively rapidly.[A252667] … [A252667,A252642] Due to a favorable pharmacological profile, a phase 1 study of enzalutamide was initiated in July 2007.

    Categories: Heterocyclic Compounds, 1-RingProducts: Enzalutamid 1A Pharma 40 mg - Filmtabletten, Enzalutamid 1A Pharma 80 mg - Filmtabletten